Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
09727-cover-familiescxd.jpg

July 8, 2019 Cover

Volume 97, Issue 27

After decades of yearning for drugs, people with PKU now have 2, and a dozen more are in development

Credit: Will Ludwig/C&EN/Shutterstock

Full Article
Volume 97 | Issue 27

All Issues

How phenylketonuria, a once-neglected disease, became a proving ground for new drugs

After decades of yearning for drugs, people with PKU now have 2, and a dozen more are in development

  • Chemical makers fight new Trump tariffs

    US chemical makers worry that an additional round of taxes on Chinese goods will hurt their competitiveness

  • How to create a supportive mental health environment in your lab

    Faculty can do these 3 things to help their students struggling with mental health issues

ADVERTISEMENT
image name
Biological Chemistry

Antibodies reverse synthetic opioid overdoses in mice

New approach counters the effects of fentanyl and carfentanil that overwhelm current overdose treatments like Narcan

ADVERTISEMENT
ADVERTISEMENT